Trying and succeeding are different things. Reliance on peer-reviewed science did not help those who were injured or killed by the "safe and effective vaccine".
A Safety Study Evaluating Non-COVID-19 Mortality Risk Following COVID-19 Vaccination
Synopsis: This study found that rates of death among people who received COVID-19 vaccines were lower than those of people who did not receive COVID-19 vaccines. In the largest study of its kind to date, the authors found no increased risk of death among people who received the Pfizer-BioNTech, Moderna, or Johnson and Johnson’s Janssen (J&J/Janssen) COVID-19 vaccines.
COVID-19 Vaccination and Non-COVID-19 Mortality Risk—Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021
Synopsis: Using data from the Vaccine Safety Datalink (VSD), this study found that rates of death among people who received COVID-19 vaccines were lower than those of people who did not receive COVID-19 vaccines. The authors determined that there is no increased risk of death among COVID-19 vaccine recipients, reinforcing the safety of COVID-19 vaccines currently authorized for use in the United States.
Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021
Synopsis: The authors of this study analyzed VAERS reports of death after COVID-19 vaccination and found that rates of death after vaccination were lower than background rates of death from any cause in the general population. The findings in this study do not suggest an association between COVID-19 vaccination and overall increased rates of death.
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
Synopsis: The authors of this study reviewed the initial six months of mRNA COVID-19 vaccine safety data from December 2020 through June 2021 in VAERS and v-safe and found that the most commonly reported side effects of mRNA vaccines were mild and short in duration and that the majority of reported adverse events were not serious. The authors also reviewed death reports submitted to VAERS and found no unusual patterns of death following mRNA vaccination.